Poor disease control among insured users of high-dose combination therapy for asthma

Allergy and Asthma Proceedings

Volumn 31, Issue 1, 2010, Pages 60-67

  Broder, Michael S ^a   Chang, Eunice Y ^a   Kamath, Tripthi ^b   Sapra, Sandhya ^b  

^a PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^b GENENTECH INC   (United States)

Author keywords

Adherence; Adherence levels; Administrative claims; Compliance; Control; Controller medications; Fluticasone salmeterol; High dose combination therapy; Moderate to severe persistent asthma; Outcomes

Indexed keywords

FLUTICASONE; OMALIZUMAB; SALMETEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DRUG MEGADOSE; DRUG PREFERENCE; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; SCHOOL CHILD; SEX DIFFERENCE; SYMPTOMATOLOGY; TREATMENT REFUSAL;

ADOLESCENT; ADULT; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CHILD; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE COVERAGE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76149091193     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3302     Document Type: Article

References (34)

1. Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma - United States, 1980-2004. MMWR Morb Mortal Wkly Rep 56(SS08):1-14, 18-54, 2007.
2. National Institutes of Health. Expert panel report 3: Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI), Bethesda, MD, 2007.
3. Li JT, Oppenheimer J, Bernstein IL, et al. Attaining optimal asthma control: A practice parameter. J Allergy Clin Immunol 116:S3-S11, 2005.
4. Bender B, Milgrom H, and Apter A. Adherence intervention research: What have we learned and what do we do next? J Allergy Clin Immunol 112:489-494, 2003.
5. Haynes RB, Yao X, Degani A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev Issue 4. No. CD000011.pub2. DOI: 10.1002/14651858.CD000011.pub2, 2005.
6. Horne R. Compliance, adherence, and concordance: Implications for asthma treatment. Chest 130(suppl 1):65S-72S, 2006.
7. Strunk RC, Ford JG, and Taggart V. Reducing disparities in asthma care: Priorities for research-National Heart, Lung, and Blood Institute workshop report. J Allergy Clin Immunol 109: 229-237, 2002.
8. Bateman ED, Boushey HA, Bousquet J, et al. Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 170:836-844, 2004.
9. Lalloo UG, Malolepszy J, Kozma D, et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 123:1480-1487, 2003.
10. Peters SP, Anthonisen N, Castro M, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 356:2027-2039, 2007.
11. National Institutes of Health. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA), Bethesda, MD, 2006.
12. Healthcare Common Procedure Coding System. Chicago: American Medical Association, 171-194, 2000.
13. Naureckas ET, Dukic V, Bao X, and Rathouz P. Short-acting beta-agonist prescription fills as a marker for asthma morbidity. Chest 128:602-608, 2005.
14. Schatz M, Zeiger RS, Vollmer WM, et al. Development and validation of a medication intensity scale derived from computseverity. comput-erized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care 12:478-484, 2006.
15. Stempel DA, McLaughin TP, Stanford RH, and Fuhlbrigge AL. Patterns of asthma control: A 3-year analysis of patient claims. J Allergy Clin Immunol 115:935-939, 2005.
16. Schatz M, Mosen DM, Kosinski M, et al. Predictors of asthma control in a random sample of asthmatic patients. J Asthma 44:341-345, 2007.
17. Schatz M, Zeiger RS, Vollmer WM, et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 130:43-50, 2006.
18. Stern L, Berman J, Lumry W, et al. Medication compliance and disease exacerbation in patients with asthma: A retrospective study of managed care data. Ann Allergy Asthma Immunol 97:402- 408, 2006.
19. Wamboldt F. Improving Adherence with Asthma Therapy. Paper presented at the annual meeting of the American College of Chest Physicians, Orlando, FL. Medical Association Communications, 2003.
20. Lozano P, Sullivan SD, Smith DH, and Weiss KB. The economic burden of asthma in US children: Estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 104:957-963, 1999.
21. Redd S. Asthma in the United States: Burden and current theories. Environ Health Perspect 110(suppl 4):557-560, 2002.
22. Silverstein MD, Mair JE, Katusic SK, et al. School attendance and school performance: A population-based study of children with asthma. J Pediatr 139:278-283, 2001.
23. Skrepnek GH, and Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 10(suppl 5):S129 -S138, 2004.
24. Sullivan SD. The burden of uncontrolled asthma on the U.S. health care system. Manag Care 14(suppl 8):4-7, 2005.
25. Ungar WJ, and Coyte PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 9:37-46, 2000.
26. Wang LY, Zhong Y, and Wheeler L. Direct and indirect costs of asthma in school-age children. Prev Chronic Dis 2:A11, 2005.
27. O'Connor RD, Gilmore AS, Manjunath R, et al. Comparing outcomes in patients with persistent asthma: A registry of two therapeutic alternatives. Curr Med Res Opin 22:453- 461, 2006.
28. Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: A randomized, double-blind trial. Chest 129:246-256, 2006.
29. Bender B, Boulet LP, Chaustre I, et al. Asthma. In Adherence to Long-Term Therapies: Evidence for Action. Sabaté E. (ed.). Geneva, Switzerland: World Health Organization, 47-57, 2003.
30. Christensen DB, Williams B, Goldberg HI, et al. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother 28:99-104, 1994.
31. Maselli JH, and Gonzales R. Measuring antibiotic prescribing practices among ambulatory physicians: Accuracy of administrative claims data. J Clin Epidemiol 54:196-201, 2001.
32. Tamblyn R, Lavoie G, Petrella L, and Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 48:999-1009, 1995.
33. Christensen DB, Williams B, Goldberg HI, et al. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 35:1164-1170, 1997.
34. DiMatteo MR, Giordani PJ, Lepper HS, and Croghan TW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 40:794-811, 2002.